Page last updated: 2024-08-21

perillyl alcohol and Carcinoma in Situ

perillyl alcohol has been researched along with Carcinoma in Situ in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coop, A; Ellis, MJ; Gallagher, A; Hayes, DF; Lieberman, R; Pennanen, M; Singh, B; Stearns, V; Trock, B; Yamauchi, H	1
O'Shaughnessy, JA	1

Trials

1 trial(s) available for perillyl alcohol and Carcinoma in Situ

Article	Year
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Cohort Studies; Female; Humans; Immunohistochemistry; Middle Aged; Monoterpenes; Pilot Projects; Time Factors; Treatment Outcome	2004

Article

Year

A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22

Topics: Aged; Antineoplastic Agents; Apoptosis; Biomarkers; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Cohort Studies; Female; Humans; Immunohistochemistry; Middle Aged; Monoterpenes; Pilot Projects; Time Factors; Treatment Outcome

2004

Other Studies

1 other study(ies) available for perillyl alcohol and Carcinoma in Situ

Article	Year
Chemoprevention of breast cancer. JAMA, 1996, May-01, Volume: 275, Issue:17 Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes	1996

Article

Year

Chemoprevention of breast cancer.

JAMA, 1996, May-01, Volume: 275, Issue:17

Topics: Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Cyclohexenes; Dehydroepiandrosterone; Estrogen Antagonists; Female; Genistein; Humans; Isoflavones; Limonene; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Retinoids; Tamoxifen; Terpenes

1996